MEP35208A - Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju - Google Patents

Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju

Info

Publication number
MEP35208A
MEP35208A MEP-352/08A MEP35208A MEP35208A ME P35208 A MEP35208 A ME P35208A ME P35208 A MEP35208 A ME P35208A ME P35208 A MEP35208 A ME P35208A
Authority
ME
Montenegro
Prior art keywords
preparation
ingredients
sterile water
suspensions containing
crystal active
Prior art date
Application number
MEP-352/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Andrea Capocchi
Fausto Pivetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MEP35208A publication Critical patent/MEP35208A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/02—Non-contaminated water, e.g. for industrial water supply
    • C02F2103/026—Treating water for medical or cosmetic purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
MEP-352/08A 2002-12-18 2003-12-17 Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju MEP35208A (bs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002674A ITMI20022674A1 (it) 2002-12-18 2002-12-18 Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
PCT/EP2003/014386 WO2004054545A1 (en) 2002-12-18 2003-12-17 Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation

Publications (1)

Publication Number Publication Date
MEP35208A true MEP35208A (bs) 2011-02-10

Family

ID=32587870

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-352/08A MEP35208A (bs) 2002-12-18 2003-12-17 Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju
MEP-2008-352A ME01084B (me) 2002-12-18 2003-12-17 Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2008-352A ME01084B (me) 2002-12-18 2003-12-17 Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju

Country Status (22)

Country Link
US (1) US8128909B2 (de)
EP (1) EP1572153B1 (de)
CN (1) CN100398095C (de)
AT (1) ATE544445T1 (de)
AU (1) AU2003294879A1 (de)
BR (1) BRPI0316908B8 (de)
CA (1) CA2510263C (de)
DK (1) DK1572153T3 (de)
EA (1) EA008122B1 (de)
ES (1) ES2379349T3 (de)
HR (1) HRP20050546B1 (de)
IT (1) ITMI20022674A1 (de)
MA (1) MA27702A1 (de)
ME (2) MEP35208A (de)
MX (1) MXPA05006441A (de)
PL (1) PL213704B1 (de)
PT (1) PT1572153E (de)
RS (1) RS52151B (de)
SI (1) SI1572153T1 (de)
UA (1) UA87655C2 (de)
WO (1) WO2004054545A1 (de)
ZA (1) ZA200504897B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
ITMI20032054A1 (it) * 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1949891A1 (de) * 2004-10-12 2008-07-30 Generics (UK) Limited Verfahren zur Herstellung von Suspensionsaerosolformulierungen, wobei die Partikel durch Fällung im Innenkanister gebildet werden
EP1811981B1 (de) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
ES2388287T3 (es) 2005-01-20 2012-10-11 Eratech S.R.L. Procedimiento para la preparación de suspensiones concentradas de fármacos y kit correspondiente
EP1782797A1 (de) * 2005-11-02 2007-05-09 Pharmatex Italia Srl Verfahren zur Herstellung von sterilen pulverförmigen pharmazeutischen Verbindungen
JP2010524919A (ja) * 2007-04-23 2010-07-22 サン、ファーマスーティカル、インダストリーズ、リミテッド 医薬組成物
MY152789A (en) 2007-07-31 2014-11-28 Otsuka Pharma Co Ltd Methods for producing aripiprazole suspension and freeze-dried formulation
WO2009074666A1 (en) * 2007-12-13 2009-06-18 Novartis Ag Organic compounds
GB0806873D0 (en) * 2008-04-16 2008-05-21 Breath Ltd Steroid nebuliser formulation
CN101618019B (zh) * 2008-07-01 2011-08-03 上海通用药业股份有限公司 一种醋酸曲安奈德微粒及其制备方法和药物组合物
AU2012206621B2 (en) * 2011-01-12 2017-04-27 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
EP2704724B1 (de) 2011-05-03 2016-10-26 Chiesi Farmaceutici S.p.A. Verbesserte beclomethason-dipropionat suspensionsformulierung zur verabreichung mittels inhalation
JP4954345B1 (ja) * 2011-07-06 2012-06-13 アピ株式会社 医薬品原薬の無菌化精製装置
AU2013259872B2 (en) * 2012-05-08 2018-06-28 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
SMT202000280T1 (it) 2014-09-09 2020-07-08 Vectura Ltd Formulazione comprendente glicopirrolato, metodo ed apparecchiatura
EP3153606B1 (de) * 2015-10-09 2019-10-09 Bgh Verfahren zum kristallisieren von hydrat-clathraten, und verfahren zur reinigung einer wässrigen flüssigkeit anhand der so kristallisierten hydrat-clathrate
WO2024180569A1 (en) * 2023-03-01 2024-09-06 Ajaykumar Balraj Kanduri A synergistic aqueous nebulization suspension for management of infectious respiratory disorders and process of preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107715B (en) * 1981-10-19 1985-11-13 Glaxo Group Ltd Micronised beclomethasone dipropionate monohydrate and powder inhalation compositions containing it
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
ID27887A (id) * 1998-04-18 2001-05-03 Glaxo Group Ltd Formulasi aerosol farmasi
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
IT1303692B1 (it) 1998-11-03 2001-02-23 Chiesi Farma Spa Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0016040D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
AU2003246829A1 (en) * 2002-02-19 2003-09-09 Resolution Chemicals Limited Solvent-based sterilisation of pharmaceuticals

Also Published As

Publication number Publication date
HRP20050546A2 (en) 2005-10-31
EP1572153A1 (de) 2005-09-14
ME01084B (me) 2011-05-10
MA27702A1 (fr) 2006-01-02
BRPI0316908B8 (pt) 2021-05-25
BRPI0316908B1 (pt) 2016-01-26
ITMI20022674A1 (it) 2004-06-19
ES2379349T3 (es) 2012-04-25
DK1572153T3 (da) 2012-03-05
UA87655C2 (ru) 2009-08-10
EA008122B1 (ru) 2007-04-27
MXPA05006441A (es) 2005-09-08
PT1572153E (pt) 2012-03-22
RS52151B (sr) 2012-08-31
CN100398095C (zh) 2008-07-02
PL377345A1 (pl) 2006-01-23
CA2510263C (en) 2012-07-03
HK1088217A1 (zh) 2006-11-03
BR0316908A (pt) 2005-10-18
EA200500833A1 (ru) 2006-02-24
EP1572153B1 (de) 2012-02-08
HRP20050546B1 (hr) 2014-05-23
PL213704B1 (pl) 2013-04-30
ZA200504897B (en) 2006-09-27
US20070140980A1 (en) 2007-06-21
CA2510263A1 (en) 2004-07-01
US8128909B2 (en) 2012-03-06
AU2003294879A1 (en) 2004-07-09
ATE544445T1 (de) 2012-02-15
WO2004054545A1 (en) 2004-07-01
CN1735403A (zh) 2006-02-15
RS72504A (sr) 2006-10-27
SI1572153T1 (sl) 2012-05-31

Similar Documents

Publication Publication Date Title
MEP35208A (bs) Pripremanje sterilnih vodenih suspenzija koje sadrže mikronizovane kristalne aktivne sastojke za inhalaciju
PH12020551256A1 (en) Salts, crystal forms, and production methods thereof
BR0307267A (pt) Compostos heterocìclicos, ativos como inibidores de beta-lacta-mases
DK1406876T3 (da) 2-anilinopyrimidinderivater som inhibitorer af cyclinafhængige kinaser
NO20032111L (no) Nye medikamentblandinger basert pa tiotropium-salter og pa salmeterol-salter
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
MY130803A (en) New quinuclidine amide derivatives
NO20076695L (no) Nye MCHR1-antagonister og deres anvendelse for behandling av MCHR1-medierte tilstander og forstyrrelser
NO20065904L (no) Terapeutiske forbindelser
NO20045486L (no) Nye forbindelser og deres anvendelse
BR0304821A (pt) Processo de preparação de uma suspensão estéril de partìculas de corticosteróide para administração por inalação
MEP46708A (en) Micronized crystalline tiotropium bromide
SE0402762D0 (sv) Indazole sulphonamide derivatives
SE9904413D0 (sv) Comminuted form
BRPI0411936A (pt) composto, processo para a sua preparação, composição farmacêutica que comprende o mesmo, utilização de um composto, métodos para o tratamento e profilaxia de distúrbios do sistema nervoso central, alimentares e obesidade
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
BRPI0410050A (pt) método de tratamento ou de profilaxia de distúrbios psicóticos, distúrbios de prejuìzo intelectual ou doenças ou condições nos quais a modulação do receptor alfa7-nicotìnico é benéfica, composição farmacêutica, método de tratamento ou de profilaxia de doenças, uso de um composto, composto, e, método de preparação de um composto
DK1746980T3 (da) Farmaceutisk doseringsform omfattende pellets såvel som deres fremstillingsfremgangsmåde
MEP54208A (en) Medicaments containing steroids and a novel anticholinesterase drug
TW200800977A (en) A new salt
AU2002358819A1 (en) Aqueous base liquid pharmaceutical compositions in suspension form for the oral administration of ibuprofen
ATE487478T1 (de) Herstellung eines neuen pharmazeutisch geeigneten losartan-salzes und von seinen formen mittels neuer reinigungs- und isolationsverfahren
AP2002002679A0 (en) Novel polymorph V of torasemide.
PT1198224E (pt) Formulacoes de solucoes de esteroides para administracao por inalacao
TW200745155A (en) Preparation of pharmaceutical salts of 3-O-(3',3'-dimethylsuccinyl)betulinic acid